Financial reports
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
10-K
2022 FY
Annual report
24 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
10-K
2021 FY
Annual report
15 Feb 22
10-Q
2021 Q3
Quarterly report
3 Nov 21
Current reports
8-K/A
Departure of Directors or Certain Officers
17 Apr 24
8-K
UnitedHealth Group Reports First Quarter 2024 Results
16 Apr 24
8-K
Departure of Directors or Certain Officers
28 Mar 24
8-K
Other Events
21 Mar 24
8-K/A
UnitedHealth Group Update on Change Healthcare Cyberattack
8 Mar 24
8-K
1.05
22 Feb 24
8-K
Other Events
9 Feb 24
8-K
Departure of Directors or Certain Officers
7 Feb 24
8-K
UnitedHealth Group Reports 2023 Results
12 Jan 24
8-K
Other Events
29 Dec 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
20 Mar 24
FWP
Free writing prospectus
19 Mar 24
424B5
Prospectus supplement for primary offering
19 Mar 24
424B5
Prospectus supplement for primary offering
24 Mar 23
FWP
Free writing prospectus
23 Mar 23
424B5
Prospectus supplement for primary offering
23 Mar 23
S-3ASR
Automatic shelf registration
3 Mar 23
S-8
Registration of securities for employees
3 Mar 23
S-8
Registration of securities for employees
22 Feb 23
424B5
Prospectus supplement for primary offering
26 Oct 22
Proxies
DEFA14A
Additional proxy soliciting materials
22 Apr 24
DEF 14A
Definitive proxy
22 Apr 24
PX14A6G
Letter to shareholders
25 May 23
DEFA14A
Additional proxy soliciting materials
25 May 23
DEFA14A
Additional proxy soliciting materials
25 May 23
PX14A6G
Letter to shareholders
3 May 23
DEFA14A
Additional proxy soliciting materials
21 Apr 23
DEF 14A
Definitive proxy
21 Apr 23
DEFA14A
Additional proxy soliciting materials
27 May 22
DEFA14A
Additional proxy soliciting materials
22 Apr 22
Other
CORRESP
Correspondence with SEC
29 Jan 20
UPLOAD
Letter from SEC
11 Apr 18
EFFECT
Notice of effectiveness
4 Apr 17
EFFECT
Notice of effectiveness
22 Mar 17
CORRESP
Correspondence with SEC
20 Mar 17
CORRESP
Correspondence with SEC
3 Mar 17
NO ACT
No action letter
2 Mar 17
UPLOAD
Letter from SEC
28 Feb 17
NO ACT
No action letter
14 Feb 17
NO ACT
No action letter
10 Feb 17
Ownership
4
TIMOTHY PATRICK FLYNN
3 Apr 24
4
RICE VALERIE MD MONTGOMERY
3 Apr 24
3
Heather Cianfrocco
3 Apr 24
4
Charles D. Baker
3 Apr 24
4
PAUL R GARCIA
3 Apr 24
4
Kristen Gil
3 Apr 24
4
FREDERICK WILLIAM MCNABB III
3 Apr 24
4
John H Noseworthy
3 Apr 24
4
MICHELE J HOOPER
3 Apr 24
4
STEPHEN J HEMSLEY
3 Apr 24